Conclusions
Our findings suggest questions that might be addressed in a larger study. It might be possible to restrict imaging investigation to women who have both markers elevated, thereby saving resources. It also might be possible to explore a lower cut off value for CA125. This would improve the sensitivity of CA125 for ovarian cancer detection if specificity could be maintained when a simultaneous low-range HE4 excluded ovarian malignancy.